Back To Search Results

Lumbosacral Plexopathy

Editor: Sajid Hameed Updated: 7/6/2025 10:14:19 PM

Introduction

The lumbosacral plexus is a network of nerves formed by the anterior rami of the lumbar and sacral spinal cord, involving the L1 to S4 nerve roots. Lumbosacral plexopathy is an injury to the lumbar and sacral plexus nerves. Lumbosacral plexopathy is not an uncommon condition, but it can be difficult to diagnose and manage.[1] However, this condition is far less common than brachial plexopathy. Patients with lumbosacral plexopathy usually present with low back and leg pain. Patients may also experience motor weakness, other sensory symptoms of numbness, paresthesia, and sphincter dysfunction.[2][3] 

Lumbosacral plexopathy can be caused by multiple etiologies, with diabetes mellitus, traumatic injury, neoplasms, penetrating trauma, and pregnancy being a few of the primary causes. Treatment is often limited and varies significantly depending on the underlying pathology.[4] Lumbosacral plexopathy can be debilitating, severely affecting a patient's quality of life. Therefore, early identification and initiation of effective management are critical in reducing morbidity and mortality.[5]

Etiology

Register For Free And Read The Full Article
Get the answers you need instantly with the StatPearls Clinical Decision Support tool. StatPearls spent the last decade developing the largest and most updated Point-of Care resource ever developed. Earn CME/CE by searching and reading articles.
  • Dropdown arrow Search engine and full access to all medical articles
  • Dropdown arrow 10 free questions in your specialty
  • Dropdown arrow Free CME/CE Activities
  • Dropdown arrow Free daily question in your email
  • Dropdown arrow Save favorite articles to your dashboard
  • Dropdown arrow Emails offering discounts

Learn more about a Subscription to StatPearls Point-of-Care

Etiology

Anatomical Overview

The lumbosacral plexus is a combination of lumbar and sacral plexuses and encompasses the anterior rami of the L1 through S4 nerve roots of the peripheral nervous system, with a small contribution from T12 as well. The lumbar plexus lies above the pelvic brim and forms from L1 through L4 nerve roots, while the S1 through S4 nerve roots make up the sacral plexus, which lies below the pelvic brim. 

Lumbar plexus

The lumbar plexus is formed by the anterior rami of the first 4 lumbar nerves, which descend through the psoas muscle and bifurcate into anterior and posterior divisions. These divisions subsequently branch out to form the individual nerves of the plexus. Specifically, the femoral nerve originates from the posterior divisions of the L2 to L4 nerve roots, whereas the obturator nerves are derived from their anterior counterparts. Additional components of the lumbar plexus include the iliohypogastric nerve (T12-L1), ilioinguinal nerve (L1), genitofemoral nerve (L1-L2), and lateral femoral cutaneous nerve of the thigh (L2-L3). The sciatic nerve, a major nerve of the lower limb, incorporates fibers from both the anterior and posterior divisions of the lumbosacral trunk, along with the S1 and S2 anterior rami.

Sacral plexus

The sacral plexus is primarily composed of the superior gluteal (L4-S1), inferior gluteal (L5-S2), posterior femoral cutaneous of the thigh (S1-S3), and pudendal nerve (S1-S4). The vascular supply to the lumbosacral plexus is provided by 5 lumbar arterial branches from the abdominal aorta, complemented by the deep circumflex iliac artery, the iliolumbar artery, and the gluteal branches of the internal iliac artery. This anatomical configuration is extensively documented and illustrated in several studies.[3][6][7]

Lumbosacral Plexopathy Etiologies

Since the lumbosacral plexus is present near abdominal and pelvic organs, various pathologies and injuries contribute to lumbosacral plexopathy, including:

  • Direct trauma
    • Posterior hip dislocation
    • Sacral fracture
    • After lumbar plexus block
  • Metabolic, inflammatory, and autoimmune causes [8][9][10]
    • Diabetes (more likely in those with type II diabetes, ie, diabetic amyotrophy) [11]
    • Amyloidosis
    • Sarcoidosis 
    • Post Sars CoV-2 infection (has been reported for brachial, but clinically has been seen in the lumbosacral plexus) [12]
  • Infections and local abscess [13]
    • Vertebral osteomyelitis
    • Chronic infections (eg, tuberculosis, fungal infections)
    • Other infections, eg, Lyme disease, HIV/AIDS, herpes zoster, COVID-19
    • Psoas abscess with extension (Please see StatPearls' companion resource, "Psoas Syndrome", for further information on psoas abscess) 
  • Radiation therapy of the abdominal and pelvic malignancies [14][15]
  • Pregnancy-related causes (mostly occur in the third trimester and after delivery due to birth trauma) [16] 
    • Femoral vessel catheterization
    • Ischemia from direct compression (eg, arterial pseudoaneurysms, aortic dissection, and retroperitoneal hematoma) [17]
  • Psoas muscle metastatic disease (endometrioid adenocarcinoma) mimicking a psoas abscess with resultant lumbosacral plexopathy [18]

    Damage to the vasculature innervating the lumbosacral plexus
  • Postoperative plexopathy (scar tissue formation and hematomas may occur following gynecological and other pelvic surgeries) [19]
  • Cocaine with rhabdomyolysis [20]
  • Toxicities from antineoplastic drugs (ie, ladiratuzumab vedotin) [21]

Epidemiology

Lumbosacral plexopathy presents a complex epidemiological profile due to its varied etiologies, influencing both the age of onset and overall prevalence. Typically, the median age at diagnosis across all causes is approximately 65 years. Women are disproportionately affected by lumbosacral plexopathy, largely attributed to risk factors, eg, pregnancy and gynecological cancers. Diabetic amyotrophy specifically shows an incidence rate of 4.2 per 100,000 annually [1], affecting 0.8% of individuals diagnosed with diabetes mellitus.[22] Among these patients, the median duration of diabetes before the onset of amyotrophy is 4 years, with a median hemoglobin A1c value of 7.5% at diagnosis.[9][23]

Neoplastic cases of lumbosacral plexopathy predominantly involve the L4 to S1 segments in over 50% of cases, with the L1 to L4 segments affected in 31%, and panplexopathy in approximately 10% of cases.[24] In 73% of these cases, the plexopathy is associated with local compression or invasion by an abdominopelvic malignancy. Notably, lumbosacral plexopathy manifests within a year of diagnosing primary tumors in over one-third of the affected patients, and in 15% of these cases, the plexopathy itself leads to the cancer diagnosis.[25][26]

Traumatic incidents also contribute to lumbosacral plexopathy incidence, with about 0.7% following traumatic pelvic fractures, and increasing to 2% following postsacral fractures.[27] Additionally, lumbosacral plexopathy occurs in approximately 1 in 2000 to 6400 deliveries.[28] Furthermore, the incidence of retroperitoneal hematoma following femoral artery catheterization stands at only 0.5%. However, about 20% of these cases develop subsequent femoral neuropathy, and 9% progress to lumbosacral plexopathy.[29]

Pathophysiology

The pathophysiology of lumbosacral plexopathy varies based on the following etiologies:

  • Trauma (ie, injury or traction on the plexus)
  • Tumor, eg, infiltration by the tumor or metastasis, intraneural lymphomatosis, the perineural spread of prostate cancer
  • Radiation (endothelial damage leading to chronic inflammatory cell migration and a state of fibrosis, followed by an irreversible state of microvascular injury and ischemic damage)
  • Hematoma due to compression of the nerve plexus
  • Diabetic and nondiabetic lumbosacral plexopathy caused by inflammatory or microvascular changes
  • Vascular endoleak complication after an endovascular aneurysm repair [30]

Histopathology

In cases of malignancy extending to and causing plexopathy, the histopathology of the malignancy would be determined by biopsy, potentially receptor tested, and treated based on the oncologic standard of care for that case.

Toxicokinetics

Antineoplastic, specifically ladiratuzumab vedotin, has been shown to have an affiliation. Additionally, cocaine has been documented, especially with concomitant rhabdomyolysis, to have an association.

History and Physical

A comprehensive clinical history and meticulous physical examination are essential for diagnosing lumbosacral plexopathy. Typically, patients report low back pain that radiates to 1 side, often exacerbated in a supine position. However, bilateral lumbosacral plexopathy has been reported in sarcoidosis as well as pregnancy.[31]

Clinical History

The clinical presentation can vary secondary to the underlying etiology. Patients with diabetic lumbosacral plexopathy usually experience unilateral pain in the proximal thigh, accompanied by numbness, paresthesias, or dysesthesias in the lower limbs, predominantly on 1 side. Conversely, lumbosacral plexopathy resulting from radiotherapy often manifests without pain. Furthermore, the symptom onset can range from acute (eg, motor vehicular collisions) to chronic, as seen after radiotherapy.

In severe cases, muscle weakness and atrophy may be noted. While sphincter dysfunction is uncommon, its presence could indicate cauda equina syndrome.[32] Systemic symptoms, eg, fever, chills, night sweats, fatigue, and weight loss, may indicate underlying malignancy or infection. Pertinent history may include exposure to factors, including road traffic accidents, abdominopelvic neoplasms, radiotherapy, abdominal surgery, diabetes mellitus, bleeding disorders, or recent pregnancy, which can guide the identification of the etiology of lumbosacral plexopathy.

Physical Examination

Physical examination findings vary; mild cases may appear normal, whereas trauma cases might show bruises. The straight leg raise test is often positive in over half the patients. Asymmetric lower limb muscle weakness and correspondingly diminished or absent deep tendon reflexes may be noted, with the knee jerk reflex commonly impacted in lumbar plexopathy and the ankle jerk reflex in sacral plexopathy. Muscle weakness involving hip flexion, knee extension, or adduction could indicate damage to the lumbar plexus. During a physical exam, acute or chronic foot drop is the most common initial sign of ALS.[33]

Sensory loss may follow a dermatomal pattern for proximal lumbosacral plexopathy involving nerve roots or a nerve distribution pattern. Sensory alterations in the medial thigh, anterior thigh, and medial leg suggest lumbar plexus involvement, whereas changes in the posterior thigh, dorsum of the foot, and perineum point to sacral plexus involvement. Spinal point tenderness is notable in cases of sacral fracture or infection. During examination, a rectal exam is advisable to assess rectal tone. Although rare, saddle anesthesia and bowel or bladder incontinence may also occur, complicating differentiation from cauda equina and conus medullaris syndromes. The inguinal region should be palpated for potential hematomas.

Evaluation

Neuroimaging, specifically magnetic resonance imaging (MRI) of the lumbosacral spine, and electrodiagnostic studies, eg, nerve conduction study and electromyography, are essential in the confirmation of the diagnosis of lumbosacral plexopathy. 

Imaging Studie

MRI with gadolinium contrast is the best test for the evaluation of the lumbosacral plexus. When contraindications to MRI (eg, a noncompatible pacemaker) are identified, a computed tomography (CT) scan with contrast can be utilized.[34][35] MR neurography is a useful modality compared to traditional MRI in lumbosacral plexopathy evaluation. Neurography helps identify extraspinal injuries responsible for neuropathic leg pain.[35] Recently, high-resolution ultrasounds have also been shown to be an excellent alternative for dynamic evaluation and visualization of the nerve architecture, and can be used as an affordable first step for diagnosticians trained in ultrasound imaging.[36]

In cases of malignancy, differentiating direct compression from metastatic disease can be challenging. Thus, advanced imaging is often needed.[37] MRI is often ordered for the initial evaluation of neoplasm-associated lumbosacral plexopathy. Positron emission tomography (PET) is used to determine the full extent of malignancy.[26] PET scans also help in staging the disease, subsequent treatment, and prognosis.

Electrodiagnostic Studies

Electrodiagnostic studies, eg, electromyography (EMG), help differentiate lumbosacral plexopathy from other types of neuropathy or radiculopathies. Electromyography helps in the localization of neurological injury. EMG can also help differentiate malignancy from radiation-induced plexopathy.[38][39] Myokymic discharges occur in cases of radiation-induced plexopathy but do not occur in cases of neoplasm. Myokymia is the spontaneous burst of an individual motor unit. These bursts occur several times per second and rhythmically. Denervation of the paraspinal muscles is commonly seen in radiculopathy and helps to differentiate from lumbosacral plexopathy.[2] Magnetic nerve root stimulation can aid in the diagnosis of patients with contraindications to EMG (eg, bleeding disorders). The use of magnetic root stimulation for a more extensive analysis of nerve root damage has been reported in challenging cases of lumbosacral plexopathy.[40] 

Laboratory Investigations

Recommended blood tests to identify the etiology in patients with lumbosacral plexopathy should include a complete blood count with an erythrocyte sedimentation rate, C-reactive protein, coagulation studies, autoantibodies testing (eg, antinuclear antibodies, antineutrophil cytoplasmic antibodies, anti-Sjögren-syndrome-related antigen A, and anti-Ro/anti-La antibodies), and hemoglobin A1c. Furthermore, serum protein electrophoresis, angiotensin-converting enzyme levels, human immunodeficiency virus (HIV), Lyme antibodies, rapid plasma reagin, and Epstein-Barr virus serology may be indicated for specific cases.[41]

Additional Diagnostic Studies

If the cause of lumbosacral plexopathy is still not identified despite the above investigations, it indicates the need for a lumbar puncture. When malignancy is found, a biopsy of pelvic organs, as well as a biopsy of the suspected affected nerve root, is needed. Sciatic nerve fascicular biopsies aid in diagnosis for complex cases and cases of suspected malignancy present in the sciatic nerve distribution.[42]

Biopsy

Biopsy may be indicated in indeterminate masses compressing or metastasizing to the lumbosacral plexus. This may also be for aspiration for organisms for culture and sensitivity in the case of infectious etiology, or histopathology in the cases of malignancy. Although intramuscular metastasis is rare, sporadic cases have been documented.

Treatment / Management

The treatment of lumbosacral plexopathy primarily comprises therapy tailored to the specific underlying cause and symptomatic relief.

Supportive Treatments

Supportive therapies typically involve the administration of analgesics and muscle relaxants, including non-steroidal anti-inflammatory drugs (NSAIDs), pregabalin, gabapentin, duloxetine, amitriptyline, and opioids. For patients experiencing foot drop, ankle-foot orthoses may be beneficial. In cases of infection, appropriate antibiotics and antifungals are necessary.

Etiology-Specific Therapies

Diabetic amyotrophy, often transient, generally improves with effective glycemic control. Neuropathic pain management strategies are recommended for symptomatic relief in these patients.[4][43] Treatment options that may be considered in persistent, severe cases include steroids, intravenous immunoglobulin (IVIG), cyclophosphamide, and plasma exchange.[41](B3)

In malignancy-associated lumbosacral plexopathy, excision or appropriate management of the primary tumor is critical. For severe symptomatic cases, dorsal rhizotomy may be performed, which has been shown to significantly reduce pain and decrease opioid dependence in terminally ill patients.[44]

Radiation-induced plexopathy, often manifesting as painless weakness and sensory changes, usually occurs bilaterally and can appear years following radiation exposure.[45] No effective treatments for radiation-induced plexopathy have been established; thus, physiotherapy and rehabilitation are emphasized, and any further radiotherapy should be avoided.(B2)

Surgical intervention, eg, nerve repair techniques and nerve grafting, has shown promising results in improving muscle function following pelvic fractures. A small study involving 10 patients with traumatic lumbosacral plexopathy reported significant muscle function improvement at a 38-month followup after undergoing nerve grafting.[46][47](B3)

For patients with a retroperitoneal hematoma, conservative management typically includes blood transfusions and bed rest. Surgical intervention may be necessary if the hematoma worsens or if neurological function deteriorates.[48](B3)

Differential Diagnosis

Differential diagnoses that should also be considered when evaluating lumbosacral plexopathy include:

  • Cauda equina syndrome
  • Conus medullaris syndrome
  • Hereditary sensory and motor neuropathy (also called Charcot-Marie-Tooth disease)
  • Lumbosacral radiculopathy
  • Mononeuropathies (eg, Femoral neuropathy, sciatic neuropathy, and common femoral neuropathy)
  • Polyneuropathy (eg, diabetic neuropathy, chronic inflammatory demyelinating neuropathy, and drug-related neuropathy)
  • Spinal canal stenosis
  • Spinal cord tumors
  • Malingering
  • Somatization disorder
  • Vascular Arterial Insufficiency

Toxicity and Adverse Effect Management

Toxicity and adverse effect management depend upon the treatments required. In cases of toxicity secondary to antineoplastic treatment, it may or may not be possible to discontinue or change the regimen. A risk-benefit decision may need to be made with the patient regarding chemotherapy and radiation therapy. Numerous chemicals have been shown to cause toxic neuropathies and myopathies. In cases where cocaine is felt to be a possible etiology, cessation should be encouraged. An addiction medicine program or Cocaine Anon should be considered.

Any biopsy or abscess drainage risks are standard for those procedures and should be done in facilities with adequate equipment and personnel to manage complications. Any specific medications used should have their adverse effect profiles reviewed (ie, serotonergic, sedative, anticholinergic effects), monitored, and dose adjusted as needed.

If opiates are used, a competent adult should be trained in Narcan, usually by watching the online video, and Narcan should be prescribed, and everyone should know where it is and when to use it. In cases of end-of-life and hospice, shared decision-making should be used regarding when Narcan should no longer be used.

Prognosis

Prognosis depends upon the underlying etiology, its response to treatment, and the timing of therapeutic intervention. Prognosis is good for patients with lumbosacral plexopathy secondary to pregnancy, retroperitoneal hematoma, and diabetic amyotrophy. The majority of patients with pregnancy-related lumbosacral plexopathy have a complete resolution of their symptoms 2 to 6 months following delivery.[16][49] 

Progressive neurological deterioration is common in patients with lumbosacral plexopathy secondary to malignancy. Prognosis is abysmal in neoplastic instances, with a mean survival of 6 months. Lymphoma has been demonstrated to be the most responsive tumor to therapy.[24] At 42-month follow-up, 86% of patients diagnosed with lumbosacral plexopathy secondary to malignancy had died.

Traumatic lumbosacral plexopathies are generally considered to have an unfavorable prognosis, but a case series of 72 patients with traumatic lumbosacral plexopathies demonstrated that more than two-thirds (about 70%) of patients recovered spontaneously within 18 months.[50]

Complications

Complications associated with lumbosacral plexopathy include:

  • Progressive neurological deterioration
  • Intractable pain, eg, chronic pain syndrome 
  • Bedsores
  • Recurrent infections
  • Joint contractures
  • Depression
  • Arterial vascular insufficiency
  • Reflex sympathetic dystrophy

Deterrence and Patient Education

The patient should be educated about the nature of the disease and the underlying etiology. As previously discussed, lumbosacral plexopathy secondary to pregnancy, retroperitoneal hematoma, and diabetic amyotrophy are usually transient and improve with time. Patients with malignancy should be counseled and advised for further workup and management. Symptoms can worsen over time, requiring the patient to have assistance with ambulation and activities of daily living.

Pearls and Other Issues

Lumbosacral plexopathy may mimic dermatomal distributions. The initial presentation may be foot drop. More ominous pathologies (eg, malignancy and Lou Gehrig’s disease) are in the differential. Women are at greater risk than men. A thorough history of previous malignancies as well as risk factors for current malignancy should be performed in addition to risk factors for abscess, including intravenous drug use, previous spine injections, especially discograms. The clinician should have a low threshold for MRI with contrast. Treatment should be directed at the primary ideology. Rehabilitation efforts will be directed at the impairment and attempts to minimize disability as a result of the impairment.

Enhancing Healthcare Team Outcomes

Effective management of lumbosacral plexopathy hinges on the collaborative efforts of a diverse interprofessional team. Physicians, including primary care clinicians, neurologists, and pain specialists, play a central role in diagnosing the condition, identifying its etiology, and formulating a comprehensive treatment plan tailored to the patient's clinical presentation. Radiologists contribute to the interpretation of advanced imaging modalities, eg, MRI and MR neurography, to localize nerve involvement. Advanced practitioners and nurses are instrumental in monitoring symptom progression, administering therapies, and providing ongoing education to patients and families. Their responsibilities include promoting adherence to medication regimens, coordinating follow-up care, and monitoring for complications such as falls or worsening neurological function.

Pharmacists ensure safe and effective use of medications, particularly when managing complex pharmacological regimens for pain control, including opioids, anticonvulsants, and antidepressants. Physical and occupational therapists are essential in improving functional outcomes by developing personalized rehabilitation programs that promote mobility and independence in daily activities. Mental health professionals, eg, psychiatrists and counselors, address psychological sequelae like depression and anxiety, which often arise from chronic pain and disability. Ongoing interprofessional communication is critical in aligning goals, sharing patient progress, and adjusting care plans proactively. Care coordination not only improves patient safety and outcomes but also enhances team performance by fostering a unified, patient-centered approach that prioritizes quality of life and long-term function.

References


[1]

Ng PS, Dyck PJ, Laughlin RS, Thapa P, Pinto MV, Dyck PJB. Lumbosacral radiculoplexus neuropathy: Incidence and the association with diabetes mellitus. Neurology. 2019 Mar 12:92(11):e1188-e1194. doi: 10.1212/WNL.0000000000007020. Epub 2019 Feb 13     [PubMed PMID: 30760636]


[2]

Ehler E, Vyšata O, Včelák R, Pazdera L. Painful lumbosacral plexopathy: a case report. Medicine. 2015 May:94(17):e766. doi: 10.1097/MD.0000000000000766. Epub     [PubMed PMID: 25929915]

Level 3 (low-level) evidence

[3]

Vock P, Mattle H, Studer M, Mumenthaler M. Lumbosacral plexus lesions: correlation of clinical signs and computed tomography. Journal of neurology, neurosurgery, and psychiatry. 1988 Jan:51(1):72-9     [PubMed PMID: 3351532]


[4]

Said G, Goulon-Goeau C, Lacroix C, Moulonguet A. Nerve biopsy findings in different patterns of proximal diabetic neuropathy. Annals of neurology. 1994 May:35(5):559-69     [PubMed PMID: 8179302]


[5]

Taylor BV, Dunne JW. Diabetic amyotrophy progressing to severe quadriparesis. Muscle & nerve. 2004 Oct:30(4):505-9     [PubMed PMID: 15372438]

Level 3 (low-level) evidence

[6]

García-Manzanares MD, Forner-Cordero I, Lavara-Perona MC, Sánchez-Ponce G, Gisbert-Vicens J. Bilateral lumbosacral plexopathy after mesenteric thrombosis. Spinal cord. 1999 Jul:37(7):522-5     [PubMed PMID: 10438120]

Level 3 (low-level) evidence

[7]

Brejt N, Berry J, Nisbet A, Bloomfield D, Burkill G. Pelvic radiculopathies, lumbosacral plexopathies, and neuropathies in oncologic disease: a multidisciplinary approach to a diagnostic challenge. Cancer imaging : the official publication of the International Cancer Imaging Society. 2013 Dec 30:13(4):591-601. doi: 10.1102/1470-7330.2013.0052. Epub 2013 Dec 30     [PubMed PMID: 24433993]


[8]

Ladha SS, Dyck PJ, Spinner RJ, Perez DG, Zeldenrust SR, Amrami KK, Solomon A, Klein CJ. Isolated amyloidosis presenting with lumbosacral radiculoplexopathy: description of two cases and pathogenic review. Journal of the peripheral nervous system : JPNS. 2006 Dec:11(4):346-52     [PubMed PMID: 17117943]

Level 3 (low-level) evidence

[9]

Dyck PJ, Norell JE, Dyck PJ. Microvasculitis and ischemia in diabetic lumbosacral radiculoplexus neuropathy. Neurology. 1999 Dec 10:53(9):2113-21     [PubMed PMID: 10599791]


[10]

Agogbua C, Ajoku B, Mohamed A, Oloyede O, Aikpitanyi J. A Case of Lumbosacral Radiculoplexus Neuropathy: A Rare Complication of Diabetes Mellitus. Cureus. 2024 Dec:16(12):e75005. doi: 10.7759/cureus.75005. Epub 2024 Dec 2     [PubMed PMID: 39749046]

Level 3 (low-level) evidence

[11]

Diaz LA, Gupta V. Diabetic Amyotrophy. StatPearls. 2025 Jan:():     [PubMed PMID: 32809326]


[12]

Doğan Y, Kara M, Doğan KÇ, Kaymak B, Özçakar L. Neuralgic amyotrophy associated with COVID-19 infection: the broken bough. The Korean journal of pain. 2022 Apr 1:35(2):233-235. doi: 10.3344/kjp.2022.35.2.233. Epub     [PubMed PMID: 35354687]


[13]

Stoeckli TC, Mackin GA, De Groote MA. Lumbosacral plexopathy in a patient with pulmonary tuberculosis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2000 Jan:30(1):226-7     [PubMed PMID: 10619771]

Level 3 (low-level) evidence

[14]

Koropouli E, Leloudas C, Arkoudis NA, Daponte A, Velonakis G, Tzavella D, Kokotis P, Zouvelou V, Rentzos M. Acute Postradiation Lumbosacral Plexopathy. Neurology. 2024 Nov 26:103(10):e209972. doi: 10.1212/WNL.0000000000209972. Epub 2024 Oct 23     [PubMed PMID: 39442062]


[15]

Güler T, Yurdakul FG, Karasimav Ö, Kılıç Z, Yaşar E, Bodur H. Radiation-induced lumbosacral plexopathy and pelvic insufficiency fracture: A case report of unique coexistence of complications after radiotherapy for prostate cancer. Joint diseases and related surgery. 2024 Mar 21:35(2):455-461. doi: 10.52312/jdrs.2024.1551. Epub 2024 Mar 21     [PubMed PMID: 38727129]

Level 3 (low-level) evidence

[16]

Katirji B, Wilbourn AJ, Scarberry SL, Preston DC. Intrapartum maternal lumbosacral plexopathy. Muscle & nerve. 2002 Sep:26(3):340-7     [PubMed PMID: 12210362]


[17]

Lefebvre V, Leduc JJ, Choteau PH. Painless ischaemic lumbosacral plexopathy and aortic dissection. Journal of neurology, neurosurgery, and psychiatry. 1995 May:58(5):641     [PubMed PMID: 7745423]

Level 3 (low-level) evidence

[18]

Gunn C, Fani M. Psoas muscle metastatic disease mimicking a psoas abscess on imaging. BMJ case reports. 2022 Aug 19:15(8):. doi: 10.1136/bcr-2022-250654. Epub 2022 Aug 19     [PubMed PMID: 35985739]

Level 3 (low-level) evidence

[19]

Alsever JD. Lumbosacral plexopathy after gynecologic surgery: case report and review of the literature. American journal of obstetrics and gynecology. 1996 Jun:174(6):1769-77; discussion 1777-8     [PubMed PMID: 8678139]

Level 3 (low-level) evidence

[20]

Sweedan YG, Khilan MH, Jain A, Rane R, Waseem S. Cocaine-Induced Rhabdomyolysis Causing Lumbosacral Plexopathy in an Adult Male. Cureus. 2022 Nov:14(11):e31613. doi: 10.7759/cureus.31613. Epub 2022 Nov 17     [PubMed PMID: 36540520]


[21]

Lau J, Larick R, Mixon A. Importance of Physical Medicine and Rehabilitation in a Patient With Bilateral Lumbosacral Plexopathy Following the Course of Ladiratuzumab Vedotin for Breast Cancer: A Case Report. Cureus. 2023 Dec:15(12):e49808. doi: 10.7759/cureus.49808. Epub 2023 Dec 1     [PubMed PMID: 38161548]

Level 3 (low-level) evidence

[22]

Muniz Neto FJ, Kihara Filho EN, Miranda FC, Rosemberg LA, Santos DCB, Taneja AK. Demystifying MR Neurography of the Lumbosacral Plexus: From Protocols to Pathologies. BioMed research international. 2018:2018():9608947. doi: 10.1155/2018/9608947. Epub 2018 Jan 31     [PubMed PMID: 29662907]


[23]

Dyck PJ, Windebank AJ. Diabetic and nondiabetic lumbosacral radiculoplexus neuropathies: new insights into pathophysiology and treatment. Muscle & nerve. 2002 Apr:25(4):477-91     [PubMed PMID: 11932965]


[24]

Jaeckle KA, Young DF, Foley KM. The natural history of lumbosacral plexopathy in cancer. Neurology. 1985 Jan:35(1):8-15     [PubMed PMID: 2981417]


[25]

Ladha SS, Spinner RJ, Suarez GA, Amrami KK, Dyck PJ. Neoplastic lumbosacral radiculoplexopathy in prostate cancer by direct perineural spread: an unusual entity. Muscle & nerve. 2006 Nov:34(5):659-65     [PubMed PMID: 16810682]

Level 3 (low-level) evidence

[26]

Song EJ, Park JS, Ryu KN, Park SY, Jin W. Perineural Spread Along Spinal and Obturator Nerves in Primary Vaginal Carcinoma: A Case Report. World neurosurgery. 2018 Jul:115():85-88. doi: 10.1016/j.wneu.2018.04.030. Epub 2018 Apr 13     [PubMed PMID: 29660549]

Level 3 (low-level) evidence

[27]

Kutsy RL, Robinson LR, Routt ML Jr. Lumbosacral plexopathy in pelvic trauma. Muscle & nerve. 2000 Nov:23(11):1757-60     [PubMed PMID: 11054756]

Level 2 (mid-level) evidence

[28]

COLE JT. Maternal obstetric paralysis. American journal of obstetrics and gynecology. 1946 Sep:52():372-86     [PubMed PMID: 20998152]


[29]

Kent KC, Moscucci M, Mansour KA, DiMattia S, Gallagher S, Kuntz R, Skillman JJ. Retroperitoneal hematoma after cardiac catheterization: prevalence, risk factors, and optimal management. Journal of vascular surgery. 1994 Dec:20(6):905-10; discussion 910-3     [PubMed PMID: 7990185]

Level 2 (mid-level) evidence

[30]

Ng KG, Ho DC, Wee TC. Ischemic lumbosacral plexopathy after embolization of type 2 endoleak: Progress and functional outcome. Clinical case reports. 2021 Dec:9(12):e05182. doi: 10.1002/ccr3.5182. Epub 2021 Dec 7     [PubMed PMID: 34934498]

Level 3 (low-level) evidence

[31]

Cardona-Cardona AF, Mumtaz S, Balistreri L, Stanbourough R, Butendieck R, Wang B, Abril A, Vikas M, Berianu F. Bilateral Lumbosacral Plexopathy As the Initial Manifestation of Systemic Sarcoidosis: A Case Report. Cureus. 2024 Feb:16(2):e54086. doi: 10.7759/cureus.54086. Epub 2024 Feb 12     [PubMed PMID: 38487149]

Level 3 (low-level) evidence

[32]

Emery S, Ochoa J. Lumbar plexus neuropathy resulting from retroperitoneal hemorrhage. Muscle & nerve. 1978 Jul-Aug:1(4):330-4     [PubMed PMID: 220533]

Level 3 (low-level) evidence

[33]

Priya P, Nair A, Gowda S, Nasim S, Warrier V. Iliopsoas Abscess Mimicking a Lower Motor Neuron Lesion: A Diagnostic Challenge. Cureus. 2024 Nov:16(11):e73978. doi: 10.7759/cureus.73978. Epub 2024 Nov 19     [PubMed PMID: 39703251]


[34]

Maravilla KR, Bowen BC. Imaging of the peripheral nervous system: evaluation of peripheral neuropathy and plexopathy. AJNR. American journal of neuroradiology. 1998 Jun-Jul:19(6):1011-23     [PubMed PMID: 9672005]


[35]

Moore KR, Tsuruda JS, Dailey AT. The value of MR neurography for evaluating extraspinal neuropathic leg pain: a pictorial essay. AJNR. American journal of neuroradiology. 2001 Apr:22(4):786-94     [PubMed PMID: 11290501]

Level 3 (low-level) evidence

[36]

Vazquez Do Campo R. Brachial and Lumbosacral Plexopathies. Seminars in neurology. 2025 Feb:45(1):49-62. doi: 10.1055/s-0044-1791664. Epub 2024 Oct 17     [PubMed PMID: 39419068]


[37]

Gupta L, Yadav M, Thulkar S. 'Trident sign' in pelvis: sinister sign with poor prognosis. BMJ case reports. 2017 Aug 7:2017():. pii: bcr-2017-220460. doi: 10.1136/bcr-2017-220460. Epub 2017 Aug 7     [PubMed PMID: 28784885]

Level 3 (low-level) evidence

[38]

Aho K, Sainio K. Late irradiation-induced lesions of the lumbosacral plexus. Neurology. 1983 Jul:33(7):953-5     [PubMed PMID: 6306507]

Level 3 (low-level) evidence

[39]

Ahmad A, Barrington S, Maisey M, Rubens RD. Use of positron emission tomography in evaluation of brachial plexopathy in breast cancer patients. British journal of cancer. 1999 Feb:79(3-4):478-82     [PubMed PMID: 10027316]

Level 3 (low-level) evidence

[40]

Souayah N, Sander HW. Lumbosacral magnetic root stimulation in lumbar plexopathy. American journal of physical medicine & rehabilitation. 2006 Oct:85(10):858-61     [PubMed PMID: 16998435]

Level 3 (low-level) evidence

[41]

Bradley WG, Chad D, Verghese JP, Liu HC, Good P, Gabbai AA, Adelman LS. Painful lumbosacral plexopathy with elevated erythrocyte sedimentation rate: a treatable inflammatory syndrome. Annals of neurology. 1984 May:15(5):457-64     [PubMed PMID: 6329073]

Level 3 (low-level) evidence

[42]

Capek S, Howe BM, Tracy JA, García JJ, Amrami KK, Spinner RJ. Prostate cancer with perineural spread and dural extension causing bilateral lumbosacral plexopathy: case report. Journal of neurosurgery. 2015 Apr:122(4):778-83. doi: 10.3171/2014.12.JNS141339. Epub 2015 Feb 6     [PubMed PMID: 25658791]

Level 3 (low-level) evidence

[43]

Pascoe MK, Low PA, Windebank AJ, Litchy WJ. Subacute diabetic proximal neuropathy. Mayo Clinic proceedings. 1997 Dec:72(12):1123-32     [PubMed PMID: 9413291]

Level 3 (low-level) evidence

[44]

Son BC, Yoon JH, Kim DR, Lee SW. Dorsal rhizotomy for pain from neoplastic lumbosacral plexopathy in advanced pelvic cancer. Stereotactic and functional neurosurgery. 2014:92(2):109-16. doi: 10.1159/000360581. Epub 2014 Apr 15     [PubMed PMID: 24751463]


[45]

Thomas JE, Cascino TL, Earle JD. Differential diagnosis between radiation and tumor plexopathy of the pelvis. Neurology. 1985 Jan:35(1):1-7     [PubMed PMID: 2981416]

Level 2 (mid-level) evidence

[46]

Lang EM, Borges J, Carlstedt T. Surgical treatment of lumbosacral plexus injuries. Journal of neurosurgery. Spine. 2004 Jul:1(1):64-71     [PubMed PMID: 15291023]

Level 3 (low-level) evidence

[47]

Tung TH, Martin DZ, Novak CB, Lauryssen C, Mackinnon SE. Nerve reconstruction in lumbosacral plexopathy. Case report and review of the literature. Journal of neurosurgery. 2005 Jan:102(1 Suppl):86-91     [PubMed PMID: 16206740]

Level 3 (low-level) evidence

[48]

Kaymak B, Ozçakar L, Cetin A, Erol O, Akoğlu H. Bilateral lumbosacral plexopathy after femoral vein dialysis: synopsis of a case. Joint bone spine. 2004 Jul:71(4):347-8     [PubMed PMID: 15288864]

Level 3 (low-level) evidence

[49]

Richards A, McLaren T, Paech MJ, Nathan EA, Beattie E, McDonnell N. Immediate postpartum neurological deficits in the lower extremity: a prospective observational study. International journal of obstetric anesthesia. 2017 May:31():5-12. doi: 10.1016/j.ijoa.2017.04.002. Epub 2017 Apr 8     [PubMed PMID: 28487040]

Level 2 (mid-level) evidence

[50]

Garozzo D, Zollino G, Ferraresi S. In lumbosacral plexus injuries can we identify indicators that predict spontaneous recovery or the need for surgical treatment? Results from a clinical study on 72 patients. Journal of brachial plexus and peripheral nerve injury. 2014 Jan 11:9(1):1. doi: 10.1186/1749-7221-9-1. Epub 2014 Jan 11     [PubMed PMID: 24410760]